'Madu tualang' honey as prophylaxis against febrile neutropenia in patients with haematological malignancy

Recruiting

• Conditions: Febrile Neutropenia; Haematological malignancies; Alternative and Complementary Medicine - Other alternative and complementary medicine; Infection - Studies of infection and infectious agents; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

• Registration Number: ACTRN12609000860268
• Lead Sponsor: niversiti Sains Malaysia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-10-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

Confirmed to suffer from blood cancer and Plan to receive at least 2 cycles of same chemotherapy regime.
Functional status of European Cooperative Oncology Group (ECOG) score of 3 and better.
Consented and signed the consent form.

Exclusion Criteria

history of allergy to ciprofloxacin.
history of allergy to honey product.
undergoing high dose chemotherapy for stem cell transplantation.
serius diabetes requiring intravenous insulin infusion.
pregnant or breast-feeding.
already ommenced on antibiotics for other than prophylactic indications prior to chemotherapy making the use of ciprofloxacin unnecessary.
Impaired renal function (serum creatinine > 300 micromol/L).
Impaired liver excretory function (serum bilirubin > 85 micromol/L).
Impaired liver cell integrity (alanin transaminase [ALT] > 5x upper limit of normal

Study & Design

• Study Type: Interventional
• Study Design: Not specified